- Home
- INN vs AUTL Comparison
INN vs AUTL Comparison
Compare INN & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INN
- AUTL
- Stock Information
- Founded
- INN 2010
- AUTL 2014
- Country
- INN United States
- AUTL United Kingdom
- Employees
- INN N/A
- AUTL N/A
- Industry
- INN Real Estate Investment Trusts
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INN Real Estate
- AUTL Health Care
- Exchange
- INN Nasdaq
- AUTL Nasdaq
- Market Cap
- INN 573.5M
- AUTL 625.4M
- IPO Year
- INN 2011
- AUTL 2018
- Fundamental
- Price
- INN $5.22
- AUTL $1.78
- Analyst Decision
- INN Hold
- AUTL Strong Buy
- Analyst Count
- INN 1
- AUTL 5
- Target Price
- INN $5.75
- AUTL $9.12
- AVG Volume (30 Days)
- INN 856.2K
- AUTL 2.6M
- Earning Date
- INN 08-05-2025
- AUTL 08-12-2025
- Dividend Yield
- INN 6.15%
- AUTL N/A
- EPS Growth
- INN N/A
- AUTL N/A
- EPS
- INN N/A
- AUTL N/A
- Revenue
- INN $727,133,000.00
- AUTL $29,934,000.00
- Revenue This Year
- INN $2.58
- AUTL $472.28
- Revenue Next Year
- INN $2.29
- AUTL $114.92
- P/E Ratio
- INN N/A
- AUTL N/A
- Revenue Growth
- INN N/A
- AUTL 185.17
- 52 Week Low
- INN $3.57
- AUTL $1.11
- 52 Week High
- INN $7.22
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- INN 48.64
- AUTL 29.40
- Support Level
- INN $4.97
- AUTL $1.83
- Resistance Level
- INN $5.63
- AUTL $2.52
- Average True Range (ATR)
- INN 0.22
- AUTL 0.17
- MACD
- INN 0.00
- AUTL -0.08
- Stochastic Oscillator
- INN 59.31
- AUTL 13.68
About INN Summit Hotel Properties Inc.
Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The firm's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.